ELOCON Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Elocon, and when can generic versions of Elocon launch?
Elocon is a drug marketed by Organon and is included in three NDAs.
The generic ingredient in ELOCON is mometasone furoate. There are thirty drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the mometasone furoate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Elocon
A generic version of ELOCON was approved as mometasone furoate by PADAGIS US on March 18th, 2002.
Summary for ELOCON
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 79 |
Clinical Trials: | 3 |
Patent Applications: | 4,548 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for ELOCON |
What excipients (inactive ingredients) are in ELOCON? | ELOCON excipients list |
DailyMed Link: | ELOCON at DailyMed |
Recent Clinical Trials for ELOCON
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
LEO Pharma | Phase 1 |
University of Oulu | Phase 4 |
Merck Sharp & Dohme Corp. | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for ELOCON
Paragraph IV (Patent) Challenges for ELOCON
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
ELOCON | Topical Solution (Lotion) | mometasone furoate | 0.1% | 019796 | 1 | 2004-06-10 |
US Patents and Regulatory Information for ELOCON
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Organon | ELOCON | mometasone furoate | CREAM;TOPICAL | 019625-001 | May 6, 1987 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Organon | ELOCON | mometasone furoate | OINTMENT;TOPICAL | 019543-001 | Apr 30, 1987 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Organon | ELOCON | mometasone furoate | CREAM;TOPICAL | 019625-002 | Apr 19, 2013 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Organon | ELOCON | mometasone furoate | LOTION;TOPICAL | 019796-001 | Mar 30, 1989 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ELOCON
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Organon | ELOCON | mometasone furoate | CREAM;TOPICAL | 019625-001 | May 6, 1987 | ⤷ Try a Trial | ⤷ Try a Trial |
Organon | ELOCON | mometasone furoate | CREAM;TOPICAL | 019625-001 | May 6, 1987 | ⤷ Try a Trial | ⤷ Try a Trial |
Organon | ELOCON | mometasone furoate | OINTMENT;TOPICAL | 019543-001 | Apr 30, 1987 | ⤷ Try a Trial | ⤷ Try a Trial |
Organon | ELOCON | mometasone furoate | LOTION;TOPICAL | 019796-001 | Mar 30, 1989 | ⤷ Try a Trial | ⤷ Try a Trial |
Organon | ELOCON | mometasone furoate | LOTION;TOPICAL | 019796-001 | Mar 30, 1989 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ELOCON
See the table below for patents covering ELOCON around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
New Zealand | 199600 | 17-(HETEROCYCLIC CARBOXYLATE)-SUBSTITUTED STEROIDS | ⤷ Try a Trial |
Ireland | 820207 | ⤷ Try a Trial | |
Norway | 175762 | ⤷ Try a Trial | |
Mexico | 9203403 | CARBOXILATOS HETEROCICLICOS 17-AROMATICOS DE 3,20-DIOXO-1,4-PREGNADIENO 17&-OL. | ⤷ Try a Trial |
European Patent Office | 0057401 | AROMATIC HETEROCYCLIC ESTERS OF STEROIDS, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | ⤷ Try a Trial |
Spain | 2038643 | ⤷ Try a Trial | |
Norway | 890271 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for ELOCON
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
3043773 | 21C1057 | France | ⤷ Try a Trial | PRODUCT NAME: MOMETASONE OU L'UN DE SES SELS AVEC OLOPATADINE OU L'UN DE SES SELS; NAT. REGISTRATION NO/DATE: NL52121 20211026; FIRST REGISTRATION: AT - 140638 20210426 |
0057401 | 94C0002 | Belgium | ⤷ Try a Trial | PRODUCT NAME: MOMETASONI FUROAS; NAT. REG.: 304 S 131 F 7 19930813; FIRST REG.: GR 10681/89 19900622 |
3043773 | 2022C/520 | Belgium | ⤷ Try a Trial | PRODUCT NAME: MOMETASONE OF EEN ZOUT HIERVAN EN OLOPATADINE OF EEN ZOUT HIERVAN; AUTHORISATION NUMBER AND DATE: BE595626 20220203 |
0548114 | SPC/GB97/064 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: MOMETASONE FUROATE MONOHYDRATE; REGISTERED: FR AMM 343012.6 19970219; UK 00201/0216 19970410 |
3043773 | 2190041-0 | Sweden | ⤷ Try a Trial | PRODUCT NAME: MOMETASONE OR A SALT THEREOF AND OLOPATADINE OR A SALT THEREOF; NAT. REG. NO/DATE: MT NR 60226 20210519; FIRST REG.: AT APPROVAL NR 140638 20210426 |
0057401 | SPC/GB93/085 | United Kingdom | ⤷ Try a Trial | SPC/GB93/085, EXPIRES: 20050621 |
0057401 | 94C0003 | Belgium | ⤷ Try a Trial | PRODUCT NAME: MOMETASONI FUROAS; NAT REG.: 304 S 132 F 11 19930813; FIRST REG.: GR 10683/89 19900622 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |